搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
13 小时
Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say
Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.
lupus.bmj
11 小时
Medication-related hospitalisations in patients with SLE
Objectives Patients with SLE take multiple medications. Within a large prospective longitudinal SLE cohort, we characterised ...
来自MSN
15 小时
Telehealth Companies Boost Ad Spending While Taking on More Complex Medicine
Telehealth startups including Ro and Nurx are spending millions to promote themselves as easy dispensers of medicines. Some ...
Knowridge
18 小时
High blood pressure drugs may increase risk of inflammatory disease
The team, led by Hye Sun Gwak, analyzed data from 13 studies and found that several types of blood pressure medications—ACE ...
12 分钟
on MSN
FDA approves first new type of pain medication in 25 years
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...
MediaPost
31 分钟
Thinner Amid Gluttony? Hims & Hers Debut First SB Ads For Weight-Loss Drugs
Telehealth company's spot decries medications from others as "priced for profits, not patients," while its own weight-loss ...
5 小时
F.D.A. Approves Drug to Treat Pain Without Opioid Effects
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
btimesonline
2 小时
FDA Greenlights Groundbreaking Pain Medication, But Is It Effective Enough?
The U.S. Food and Drug Administration (FDA) on Thursday approved Journavx, the first new class of pain medication in more ...
4 小时
Sickle cell patients share delight over approval of new treatment
NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...
10 小时
on MSN
Fox Carolina Investigates: Why prescription drugs prices are so high
Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.
Medscape
16 小时
Unsustainable Biosimilar Market Leaves Practices, Patients at a Loss
The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.
STAT
17 小时
MASH drugs reach a meaningful tipping point for patients and investors
Akero's success in reversing cirrhosis follows that of Madrigal, making analysts and investors bullish on drugs to treat ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈